G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $75 | -100.0% | 13,856 | -82.4% | 0.00% | -92.3% |
| Q3 2022 | $986,000 | +1692.7% | 78,938 | +613.2% | 0.01% | +1200.0% |
| Q2 2022 | $55,000 | -72.4% | 11,068 | -57.8% | 0.00% | -66.7% |
| Q1 2022 | $199,000 | -11.6% | 26,207 | +19.1% | 0.00% | +50.0% |
| Q4 2021 | $225,000 | -52.3% | 22,007 | -37.4% | 0.00% | -66.7% |
| Q3 2021 | $472,000 | -11.3% | 35,174 | +19.0% | 0.01% | +20.0% |
| Q4 2020 | $532,000 | +0.2% | 29,565 | -35.7% | 0.01% | -54.5% |
| Q3 2020 | $531,000 | -35.4% | 45,962 | +35.6% | 0.01% | -47.6% |
| Q2 2020 | $822,000 | +295.2% | 33,887 | +270.5% | 0.02% | +200.0% |
| Q3 2019 | $208,000 | – | 9,147 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
| CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
| Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
| Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
| Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
| Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
| Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |